|
Volumn 8, Issue 4, 2009, Pages 279-286
|
The microeconomics of personalized medicine: Today's challenge and tomorrow's promise
a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
BIOLOGICAL MARKER;
BRCA1 PROTEIN;
HYDRALAZINE PLUS ISOSORBIDE DINITRATE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
IMATINIB;
TRASTUZUMAB;
ARTICLE;
BREAST CANCER;
CANCER SCREENING;
CLINICAL TRIAL;
COLON CANCER;
COLONOSCOPY;
COST CONTROL;
COST EFFECTIVENESS ANALYSIS;
DIAGNOSTIC TEST;
DRUG INDUSTRY;
DRUG MARKETING;
FOOD AND DRUG ADMINISTRATION;
HEALTH CARE COST;
HEALTH CARE INDUSTRY;
HEALTH ECONOMICS;
HEALTH INSURANCE;
HEART FAILURE;
HEART INFARCTION;
HUMAN;
MALIGNANT NEOPLASTIC DISEASE;
MEDICAL FEE;
MEDICAL RESEARCH;
PRIORITY JOURNAL;
PRODUCT DEVELOPMENT;
REIMBURSEMENT;
RISK ASSESSMENT;
DELIVERY OF HEALTH CARE;
DIAGNOSTIC TESTS, ROUTINE;
DRUG INDUSTRY;
ECONOMICS;
HUMANS;
PERSONAL HEALTH SERVICES;
PHARMACEUTICAL PREPARATIONS;
PHARMACOGENETICS;
|
EID: 64049096916
PISSN: 14741776
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd2825 Document Type: Article |
Times cited : (145)
|
References (6)
|